Načítá se...
Aseptic Meningitis as an Immune-Related Adverse Event after Pembrolizumab
INTRODUCTION: The management of patients with advanced malignancies is challenging, although recent advances with immunotherapy have shown better outcomes. Pembrolizumab has been associated with a variety of immune-related side effects, but the occurrence of aseptic meningitis is rare. CASE: A 55-ye...
Uloženo v:
| Vydáno v: | Case Rep Oncol Med |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Hindawi
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6875007/ https://ncbi.nlm.nih.gov/pubmed/31781445 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/7183747 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|